Commentary

Self-management of type 2 diabetes? Yes!


 

References

In response to “Self-management of type 2 diabetes: A good idea—or not?” (J Fam Pract. 2013;62:244-248), our answer is a resounding Yes! In this article, the authors concluded that the evidence supporting referral to diabetes self-management programs is limited. However, evidence shows that participation in diabetes self-management education—which the authors conflated with self-monitoring of blood glucose (SMBG)—creates lasting improvement in clinical measures1 and patient satisfaction,2 as well as reduced costs.3

Monitoring is but one aspect of the self-management education and care that people with diabetes must engage in to optimize their health and wellness. The American Association of Diabetes Educators recommends that patients be educated in 7 self-care topics, including healthy eating, physical activity, medications, monitoring, problem solving, reducing risks of complications, and the psychosocial aspects of living with diabetes.4

We recommend the following:
Adopting a team approach to diabetes management, in which physicians actively engage with diabetes educators and others in the community, such as psychologists, coaches, and exercise specialists, as well as the patient’s family members and peers.
Reinforcing an informed and activated patient with self-management education and support as the cornerstone.
Reviewing SMBG data with the patient and using it to modify the treatment plan and help him or her implement it.
Referring patients to programs that are in compliance with the National Standards for Diabetes Self-Management Education and Support and accredited by the American Association of Diabetes Educators (AADE) or recognized by the American Diabetes Association (ADA).5

People with diabetes deserve to be supported in their efforts to learn not only how to self-manage their diabetes, but also to be team players, engaged with their health care team and the full range of other resources.

Deborah Greenwood, RN, MEd, CNS, BC-ADM, CDE
Roseville, Calif
Ruth D. Lipman, PhD
Chicago, Ill
Kimberly Buss, MD, MPH
Sacramento, Calif
Bruce Bagley, MD, FAAFP
Leawood, Kan

Recommended Reading

Combined angiotensin inhibition raises hyperkalemia, acute kidney injury risks
MDedge Family Medicine
ACC-AHA cardiovascular prevention guidelines drop cholesterol treatment goals
MDedge Family Medicine
World’s dialysis burden has grown 165% since 1990
MDedge Family Medicine
CORAL: No added benefit with renal stenting vs. medication alone
MDedge Family Medicine
Abandon LDL targets? Not yet
MDedge Family Medicine
Guideline authors, AHA-ACC leaders confident in risk calculator
MDedge Family Medicine
Gene variant ups chronic kidney disease risk, speeds progression in African Americans
MDedge Family Medicine
FDA lifts rosiglitazone prescribing restrictions
MDedge Family Medicine
Chelation plus vitamins halved cardiovascular events in diabetics
MDedge Family Medicine
Obese and overweight adults lost significant weight on vegetarian, vegan diets
MDedge Family Medicine